{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:17:30Z","timestamp":1758050250226,"version":"3.44.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bulcan.2022.08.004","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T08:23:44Z","timestamp":1664439824000},"page":"1109-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infections fongiques invasives chez l\u2019enfant immunod\u00e9prim\u00e9 en h\u00e9matologie p\u00e9diatrique\u00a0: recommandations de prise en charge au sein des centres de la SFCE"],"prefix":"10.1016","volume":"109","author":[{"given":"Fanny","family":"Alby-Laurent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wadi Abou","family":"Chahla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Brethon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwenaelle","family":"Gueguen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marl\u00e8ne","family":"Pasquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Pluchart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Domenech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bulcan.2022.08.004_bib0170","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020\u00a0guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"issue":"suppl_1","key":"10.1016\/j.bulcan.2022.08.004_bib0175","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"9","key":"10.1016\/j.bulcan.2022.08.004_bib0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol Biol."},{"issue":"2","key":"10.1016\/j.bulcan.2022.08.004_bib0185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441\u00a0patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0205","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpeds.2021.05.016","article-title":"Invasive fungal infections in immunocompromised children: novel insight following a national study","volume":"236","author":"Olivier-Gougenheim","year":"2021","journal-title":"J Pediatr."},{"issue":"6","key":"10.1016\/j.bulcan.2022.08.004_bib0190","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jac\/dkx045","article-title":"Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)","volume":"72","author":"Bretagne","year":"2017","journal-title":"J Antimicrob Chemother."},{"issue":"7","key":"10.1016\/j.bulcan.2022.08.004_bib0195","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid2007.140087","article-title":"Population-based analysis of invasive fungal infections, France, 2001\u20132010","volume":"20","author":"Bitar","year":"2014","journal-title":"Emerg Infect Dis."},{"issue":"Suppl 1","key":"10.1016\/j.bulcan.2022.08.004_bib0200","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: the RetroZygo Study (2005\u20132007)","volume":"54","author":"Lanternier","year":"2012","journal-title":"Clin Infect Dis."},{"issue":"12","key":"10.1016\/j.bulcan.2022.08.004_bib0210","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1016\/j.bulcan.2022.08.004_bib0215","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0220","series-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016\u00a0Update by the Infectious Diseases Society of America. Vol. 62, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America","first-page":"e1","author":"Pappas","year":"2016"},{"key":"10.1016\/j.bulcan.2022.08.004_bib0225","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/hon.2309","article-title":"Trichosporon: another yeast-like organism responsible for immune reconstitution inflammatory syndrome in patients with hematological malignancy","volume":"35","author":"Alby-Laurent","year":"2017","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2022.08.004_bib0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jinf.2013.08.011","article-title":"Superficial skin lesions positive for Fusarium are associated with subsequent development of invasive fusariosis","volume":"68","author":"Varon","year":"2014","journal-title":"J Infect."},{"issue":"5","key":"10.1016\/j.bulcan.2022.08.004_bib0245","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum mucorales PCR for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis."},{"issue":"10","key":"10.1016\/j.bulcan.2022.08.004_bib0235","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, \u03b2-D-glucan, and polymerase chain reaction-based assays for the diagnosis of invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis."},{"issue":"Suppl 3","key":"10.1016\/j.bulcan.2022.08.004_bib0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Stdy Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013\u00a0joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect."},{"issue":"3","key":"10.1016\/j.bulcan.2022.08.004_bib0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jpids\/piv014","article-title":"(1\u21923)-\u03b2-d-glucan in cerebrospinal fluid as a biomarker for candida and aspergillus infections of the central nervous system in pediatric patients","volume":"5","author":"Salvatore","year":"2016","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"3","key":"10.1016\/j.bulcan.2022.08.004_bib0250","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc."},{"issue":"3","key":"10.1016\/j.bulcan.2022.08.004_bib0255","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/ejh.12910","article-title":"Retrospective study on the incidence and outcome of proven and probable invasive fungal infections in high-risk pediatric onco-hematological patients","volume":"99","author":"Cesaro","year":"2017","journal-title":"Eur J Haematol."},{"issue":"4","key":"10.1016\/j.bulcan.2022.08.004_bib0260","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.mycmed.2017.10.004","article-title":"French recommendations on control measures to reduce the infectious risk in immunocompromised patients","volume":"27","author":"Zahar","year":"2017","journal-title":"J Mycol Med."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0265","unstructured":"Gangneux JP, Baron R, de mycologie medicale SFMM et Societe francaise dhygiene hospitaliere SF. Risque infectieux fongique et travaux en \u00e9tablissements de sant\u00e9 [Internet]. Available from: https:\/\/www.sf2h.net\/wp-content\/uploads\/2011\/03\/SF2H-SFMM_guide-risque-infectieux-fongique-et-travaux-en-ES-2011.pdf."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0270","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1200\/JCO.20.00158","article-title":"Clinical practice guideline for systemic antifungal prophylaxis in pediatric patients with cancer and hematopoietic stem-cell transplantation recipients","volume":"38","author":"Lehrnbecher","year":"2020","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.bulcan.2022.08.004_bib0275","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/INF.0000000000002353","article-title":"Use of micafungin for the prevention and treatment of invasive fungal infections in everyday pediatric care in france: results of the MYRIADE study","volume":"38","author":"Leverger","year":"2019","journal-title":"Pediatr Infect Dis J."},{"issue":"4","key":"10.1016\/j.bulcan.2022.08.004_bib0280","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/2040620711410098","article-title":"Invasive fungal infections in acute leukemia","volume":"2","author":"Bhatt","year":"2011","journal-title":"Ther Adv Hematol."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0285","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1054-3589(08)60129-5","article-title":"Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development","volume":"44","author":"Groll","year":"1998","journal-title":"Adv Pharmacol"},{"issue":"1","key":"10.1016\/j.bulcan.2022.08.004_bib0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin Microbiol Rev."},{"issue":"6","key":"10.1016\/j.bulcan.2022.08.004_bib0295","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020\u00a0guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0300","series-title":"Clinical practice guideline for the management of candidiasis: 2016\u00a0update by the Infectious Diseases Society of America. Vol. 62, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America","first-page":"e1","author":"Pappas","year":"2016"},{"issue":"4","key":"10.1016\/j.bulcan.2022.08.004_bib0305","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/ciw444","article-title":"Executive summary: practice guidelines for the diagnosis and management of aspergillosis: 2016\u00a0update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.bulcan.2022.08.004_bib0310","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/cid\/ciy859","article-title":"Voriconazole resistance and mortality in invasive aspergillosis: a multicenter retrospective cohort study","volume":"68","author":"Lestrade","year":"2019","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.bulcan.2022.08.004_bib0315","series-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","first-page":"e327","author":"Groll","year":"2014"},{"issue":"10","key":"10.1016\/j.bulcan.2022.08.004_bib0325","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3324\/haematol.2009.020073","article-title":"Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study","volume":"95","author":"Cordonnier","year":"2010","journal-title":"Haematologica."},{"issue":"5","key":"10.1016\/j.bulcan.2022.08.004_bib0165","first-page":"410","article-title":"Clinical practice update of antifungal prophylaxis in immunocompromised children","volume":"32","author":"Ramos","year":"2019","journal-title":"Rev Esp Quimioter."}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455122003393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455122003393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:35:59Z","timestamp":1757792159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455122003393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0007455122003393"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2022.08.004","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infections fongiques invasives chez l\u2019enfant immunod\u00e9prim\u00e9 en h\u00e9matologie p\u00e9diatrique\u00a0: recommandations de prise en charge au sein des centres de la SFCE","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2022.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}